Patent · US Active

Crystalline forms of (s)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazine-7-yl)ethyl)amino)pyrimidine-5-carbonitrile as inhibitors of phosphatidylinositol-3-kinase

US12180214B2 · kind B2 · utility

0Cited by

1References

18Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Zhenping Wu · Shanghai, CN
Wenji Li · Shanghai, CN
Ling FENG · Shanghai, CN

Key dates

Filing date	Jan 5, 2023
Grant date	Dec 31, 2024
Priority date	—
Expiry date	Jan 5, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile of the formula shown below, and the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.